CDKN1B and osteosarcoma: We compared the expression of p27 in osteosarcoma tumors with expression levels of key metastatic markers to identify a correlation with metastatic disease and explored p27 responses to the treatment of osteosarcoma cells with gemcitabine and AZD1775.